03:38 PM EDT, 07/01/2025 (MT Newswires) -- Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each climbing 1.4%.

The iShares Biotechnology ETF (IBB) added 0.9%.

In corporate news, RedHill Biopharma ( RDHL ) shares rose 5.8% after it said Tuesday it has started patient recruitment for a phase 2 trial of opaganib in combination with darolutamide for the treatment of metastatic castrate-resistant prostate cancer.